@article{de1ca25ed9e740e1acda794e4fc1ed55,
title = "Use and Prognostic Implications of Cardiac Troponin in COVID-19",
keywords = "COVID-19, Cardiac troponin, High sensitivity cardiac troponin, Myocardial injury, Prognosis, Risk stratification",
author = "{De Michieli}, Laura and Jaffe, {Allan S.} and Yader Sandoval",
note = "Funding Information: Dr Y. Sandoval has previously served on the Advisory Boards for Roche Diagnostics and Abbott Diagnostics without personal compensation. He has also been a speaker without personal financial compensation for Abbott Diagnostics. Dr A.S. Jaffe has consulted or presently consults for most of the major diagnostics companies, including Beckman-Coulter, Abbott, Siemens, Ortho Diagnostics, ET Healthcare, Roche, Radiometer, Sphingotec, RCE, and Amgen and Novartis. Dr L. De Michieli has nothing to disclose.",
year = "2022",
month = aug,
doi = "10.1016/j.ccl.2022.03.005",
language = "English (US)",
volume = "40",
pages = "287--300",
journal = "Cardiology clinics",
issn = "0733-8651",
publisher = "W.B. Saunders Ltd",
number = "3",
}